Volume 73, Pages S165-S172 (April 2008)

Slides:

Advertisements

Similar presentations

Stephen P. McDonald, Graeme R. Russ Kidney International

Advertisements

Home care assistance and the utilization of peritoneal dialysis

A skeptical view of assisted home peritoneal dialysis

Volume 69, Issue 1, Pages (January 2006)

Volume 59, Issue 2, Pages (February 2001)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

F.H. Bender, J. Bernardini, B. Piraino Kidney International

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Volume 69, Issue 5, Pages (March 2006)

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Pages S138-S145 (November 2006)

Use of hemodialysis and hemoperfusion in poisoned patients

Iron status and iron supplementation in peritoneal dialysis patients

Volume 64, Issue 6, Pages (December 2003)

Volume 70, Pages S38-S43 (November 2006)

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Impact of new dialysis solutions on peritonitis rates

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

C-reactive protein and dialysis access

Volume 64, Pages S3-S12 (December 2003)

Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy G. Viglino, L. Neri, S. Barbieri Kidney.

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

C-reactive protein and dialysis access

Volume 64, Issue 3, Pages (September 2003)

Inflammation and wasting in chronic kidney disease: Partners in crime

Volume 73, Issue 4, Pages (February 2008)

Volume 70, Pages S21-S25 (December 2006)

High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury D.P. Gabriel, J.T. Caramori,

Volume 80, Issue 9, Pages (November 2011)

French peritoneal dialysis registry (RDPLF): Outline and main results

F.H. Bender, J. Bernardini, B. Piraino Kidney International

A new era in phosphate binder therapy: What are the options?

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Volume 73, Pages S81-S86 (April 2008)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Benefits of preserving residual renal function in peritoneal dialysis

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

Edmund G. Lowrie Kidney International

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

Volume 73, Pages S5-S17 (April 2008)

Body size and outcomes on peritoneal dialysis in the United States

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Volume 69, Issue 10, Pages (May 2006)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 73, Pages S72-S75 (April 2008)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

A skeptical view of assisted home peritoneal dialysis

Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes Sr. Anne B. Bakewell, Rob M. Higgins, Mair.

Stephen P. McDonald, Graeme R. Russ Kidney International

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Volume 72, Issue 2, Pages (July 2007)

Volume 70, Pages S84-S90 (November 2006)

Charles A. Herzog Kidney International

Bradley A. Warady, Mwaffek Bashir, Lynn A. Donaldson

Volume 70, Issue 5, Pages (September 2006)

Volume 59, Issue 2, Pages (February 2001)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Ivan D. Maya, Michael Allon Kidney International

Volume 87, Issue 6, Pages (June 2015)

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Characteristics of sudden death in hemodialysis patients

Presentation transcript:

Volume 73, Pages S165-S172 (April 2008) Dialysis outcomes in Colombia (DOC) study: A comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia M. Sanabria, J. Muñoz, C. Trillos, G. Hernández, C. Latorre, C.S. Díaz, S. Murad, K. Rodríguez, Á Rivera, A. Amador, F. Ardila, A. Caicedo, D. Camargo, A. Díaz, J. González, H. Leguizamón, P. Lopera, L. Marín, I. Nieto, E. Vargas Kidney International Volume 73, Pages S165-S172 (April 2008) DOI: 10.1038/sj.ki.5002619 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 DOC study patients flowchart. Kidney International 2008 73, S165-S172DOI: (10.1038/sj.ki.5002619) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Survival analysis by intention-to-treat. (a) Kaplan–Meier curves for HD (light line) and PD (dark line) patients, follow-up in months (log-rank test: P<0.001) (b) Cox survival curves adjusted for covariates for HD (light line) and PD (dark line) patients, follow-up in months. Kidney International 2008 73, S165-S172DOI: (10.1038/sj.ki.5002619) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Survival analysis by intention-to-treat adjusted for age and DM. (a–d) Cox survival curves adjusted for covariates of age and DM for groups of HD (light line) and PD (dark line) patients, follow-up in months. Kidney International 2008 73, S165-S172DOI: (10.1038/sj.ki.5002619) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Survival analysis, as-treated. (a) Kaplan–Meier curves for HD (light line) and PD (dark line) patients, follow-up in months (log-rank test: P<0.0237) (b) Cox survival curves adjusted for covariates for HD (light line) and PD (dark line) patients, follow-up in months. Kidney International 2008 73, S165-S172DOI: (10.1038/sj.ki.5002619) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 Survival analysis, as-treated, adjusted for age and DM. (a–d) Cox survival curves adjusted for covariates of age and DM for HD (light line) and PD (dark line) patients, follow-up in months. Kidney International 2008 73, S165-S172DOI: (10.1038/sj.ki.5002619) Copyright © 2008 International Society of Nephrology Terms and Conditions